-
1Academic Journal
المؤلفون: Durot, E, Kanagaratnam, L, Zanwar, S, Kastritis, E, D'Sa, S, Garcia-Sanz, R, Tomowiak, C, Hivert, B, Toussaint, E, Protin, C, Abeykoon, JP, Guerrero-Garcia, T, Itchaki, G, Vos, JM, Michallet, A-S, Godet, S, Dupuis, J, Leprêtre, S, Bomsztyk, J, Morel, P, Leblond, V, Treon, SP, Dimopoulos, MA, Kapoor, P, Delmer, A, Castillo, JJ
المصدر: Haematologica , 106 (11) (2020)
مصطلحات موضوعية: Humans, Lymphoma, Large B-Cell, Diffuse, Prognosis, Proportional Hazards Models, Survival Rate, Waldenstrom Macroglobulinemia
وصف الملف: text
Relation: https://discovery.ucl.ac.uk/id/eprint/10132696/7/Bomsztyk_10085-Article%20Text-73580-2-10-20211027.pdf; https://discovery.ucl.ac.uk/id/eprint/10132696/
-
2Academic Journal
المصدر: Atención Primaria ; volume 33, issue 1, page 50-51 ; ISSN 0212-6567
-
3Academic Journal
المؤلفون: Durot, E., Kanagaratnam, L., D'sa, S., Tomowiak, C., Hivert, B., Toussaint, E., Guerrero‐Garcia, T., Itchaki, G., Vos, J., Michallet, A., Godet, S., Bomsztyk, J., Morel, P., Leblond, V., Treon, S.P., Delmer, A., Castillo, J.J.
المصدر: Hematological Oncology ; volume 37, issue S2, page 401-403 ; ISSN 0278-0232 1099-1069
-
4Electronic Resource
المؤلفون: Reagan J.L., Olszewski A.J., Fedele P., Bibas M., Grigoriadis G., Gilbertson M., Castillo J.J., Guerrero-Garcia T., Baldini F., Tchernonog E., Cartron G., Ninkovic S., Cwynarski K., Dierickx D., Tousseyn T., Lansigan F., Linnik Y., Mogollon R., Navarro J.-T.
مصطلحات الفهرس: cyclophosphamide/ae [Adverse Drug Reaction], gastrointestinal obstruction/si [Side Effect], human, infection/si [Side Effect], International Prognostic Index, letter, male, multiple cycle treatment, neuropathy/si [Side Effect], overall survival, plasmablastic lymphoma/dt [Drug Therapy], plasmablastic lymphoma/rt [Radiotherapy], plasmablastic lymphoma/th [Therapy], pleura effusion/si [Side Effect], priority journal, relapse, remission, retrospective study, salvage therapy, survival rate, thrombocytopenia/si [Side Effect], treatment response, bortezomib/ae [Adverse Drug Reaction], bortezomib/cb [Drug Combination], bortezomib/dt [Drug Therapy], bortezomib/iv [Intravenous Drug Administration], bortezomib/sc [Subcutaneous Drug Administration], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], daratumumab/dt [Drug Therapy], doxorubicin/ae [Adverse Drug Reaction], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], etoposide/ae [Adverse Drug Reaction], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], ifosfamide/cb [Drug Combination], ifosfamide/dt [Drug Therapy], prednisone/ae [Adverse Drug Reaction], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], adult, atrioventricular block/si [Side Effect], autologous stem cell transplantation, cancer radiotherapy, cancer staging, catheter thrombosis/si [Side Effect], clinical article, drug efficacy, drug safety, febrile neutropenia/si [Side Effect], female, follow up, Letter
URL: British Journal of Haematology
Click here for full text options
LibKey Link